Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

Do you expect [MYL] to receive approval at all?

I think so… eventually. As a MNTA shareholder, I’ll be content if MNTA has the only FDA-approved generic for a couple of years.

Please bear in mind that MYL’s Copaxone ANDA is 14 months behind MNTA’s in terms of when the ANDA’s were accepted by the FDA for review (Sep 2009 vs Jul 2008).